MUC1 dysregulation as the consequence of a t(1;14)(q21;q32) translocation in an extranodal lymphoma

Blood

Volumn 95, Issue 9, 2000, Pages 2930-2936

  Gilles, Frédéric ^b   Goy, André ^b   Remache, Yvonne ^b   Shue, Peter ^b   Zelenetz, Andrew D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CHROMOSOME 1; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 1; GENE CONTROL; GENE EXPRESSION; GENE LOCATION; GENE MAPPING; HUMAN; HUMAN CELL; LYMPHOMA; PRIORITY JOURNAL;

EID: 0034194177     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.9.2930.009k39_2930_2936     Document Type: Article

References (41)

1. Offit K, Wong G, Filippa DA, Tao Y, Chaganti RS. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations. Blood. 1991;77:1508.
2. Ye BH, Lista F, Lo Coco F, et al. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science. 1993;262:747.
3. Willis TG, Zalcberg IR, Coignet LJ, et al. Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21. Blood. 1998;91:1873.
4. Rao PH, Houldsworth J, Dyomina K, et al. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood. 1998;92:234.
5. Hatzivassiliou G, Iida S, Rao PH, et al. Two novel genes related to the Fc receptor family involved in the t(1;14)(q21;q32) chromosomal translocation in multiple myeloma. In: Program and Abstracts of the Annual Meeting of the American Society of Hematology; 1998; Miami Beach, FL. Abstract 2093.
6. Tweeddale ME, Lim B, Jamal N, et al. The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor. Blood. 1987;69: 1307.
7. Fukuhara S, Ohno H, Amakawa R, et al. Significance of extra 18q-chromosome in Japanese t(14;18)-positive lymphoma. Blood. 1988;71:1748.
8. Zelenetz AD, Chen TT, Levy R. Histologic transformation of follicular lymphoma to diffuse lymphoma represents tumor progression by a single malignant B cell. J Exp Med. 1991;173: 197.
9. Nilsson K, Ponten J. Classification and biological nature of established human hematopoietic cell lines. Int J Cancer. 1975;15:321.
10. Harnden DG, Klinger HP. An international system for human cytogenetic nomenclature Basel, Switzerland: Karger; 1985.
11. Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci U S A. 1986;83:2934.
12. Zelenetz AD, Chu G, Galili N, et al. Enhanced detection of the t(14;18) translocation in malignant lymphoma using pulsed-field gel electrophoresis. Blood. 1991;78:1552.
13. Hanahan D, Meselson M. Plasmid screening at high colony density. Methods Enzymol. 1983;100: 333.
14. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680.
15. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350.
16. Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl Acids Res. 1997;25:3389.
17. Winfield SL, Tayebi N, Martin BM, Ginns EI, Sidransky E. Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: implications for Gaucher disease [letter] [see comments]. Genome Res. 1997;7:1020.
18. Adolph KW, Long GL, Winfield S, Ginns EI, Bornstein P. Structure and organization of the human thrombospondin 3 gene (THBS3). Genomics. 1995;27:329.
19. Ligtenberg MJ, Vos HL, Gennissen AM, Hilkens J. Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini. J Biol Chem. 1990;265:5573.
20. Nakamori S, Ota DM, Cleary KR, Shirotani K, Irimura T. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology. 1994;106:353.
21. McGuckin MA, Walsh MD, Hohn BG, Ward BG, Wright RG. Prognostic significance of MUC1 epithelial mucin expression in breast cancer. Hum Pathol. 1995;26:432.
22. Giuntoli RL II, Rodriguez GC, Whitaker RS, Dodge R, Voynow JA. Mucin gene expression in ovarian cancers. Cancer Res. 1998;58:5546.
23. Agrawal B, Krantz MJ, Reddish MA, Longenecker BM. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2 [see comments]. Nat Med 1998;4:43.
24. Takahashi T, Makiguchi Y, Hinoda Y, et al. Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient. J Immunol. 1994;153:2102.
25. Noto H, Takahashi T, Makiguchi Y, Hayashi T, Hinoda Y, Imai K. Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form ot MUC1 mucin. Int Immunol. 1997; 9:791.
26. Keung YK, Yung C, Wong JW, Shah F, Cobos E, Tonk V. Unusual presentation of multiple myeloma with "jumping translocation" involving 1q21: a case report and review of the literature. Cancer Genet Cytogenet. 1998;106:135.
27. Hilkens J, Ligtenberg MJ, Vos HL, Litvinov SV. Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem Sci. 1992;17:359.
28. Ligtenberg MJ, Buijs F, Vos HL, Hilkens J. Suppression of cellular aggregation by high levels of episialin. Cancer Res. 1992;52:2318.
29. Foreman KE, Bacon PE, Hsi ED, Nickoloff BJ. In situ polymerase chain reaction-based localization studies support role of human herpesvirus-8 as the cause of two AIDS-related neoplasms: Kaposi's sarcoma and body cavity lymphoma. J Clin Invest. 1997;99:2971.
30. Delsol G, Al Saati T, Gatter KC, et al. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas: diagnostic value in so-called malignant histiocytosis. Am J Pathol. 1988;130:59.
31. Carbone A, Gloghini A, De Re V, Tamaro P, Boiocchi M, Volpe R. Histopathologic, immunophenotypic, and genotypic analysis of Ki-1 anaplastic large cell lymphomas that express histiocyte-associated antigens. Cancer. 1990;66:2547.
32. Chhanabhai M, Britten C, Klasa R, Gascoyne RD. t(2;5) positive lymphoma with peripheral blood involvement. Leuk Lymphoma. 1998;28: 415.
33. Knowles D. Neoplastic Hematopathology. Baltimore, MD: Williams & Wilkins; 1992:341.
34. Chen C, Birshtein BK. Virtually identical enhancers containing a segment of homology to murine 3'IgH-E(hs1,2) lie downstream of human Ig C alpha 1 and C alpha 2 genes. J Immunol. 1997; 159:1310.
35. Arulampalam V, Grant PA, Samuelsson A, Lendahl U, Pettersson S. Lipopolysaccharide-dependent transactivation of the temporally regulated immunoglobulin heavy chain 3′ enhancer. Eur J Immunol. 1994;24:1671.
36. Seto M, Jaeger U, Hockett RD, et al. Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-lg fusion gene in lymphoma. EMBO J. 1988;7:123.
37. Raynaud SD, Bekri S, Leroux D, et al. Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies. Genes Chromosomes Cancer. 1993;8:80.
38. Williams ME, Swerdlow SH, Rosenberg CL, Arnold A. Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia. 1993;7:241.
39. Graham M, Adams JM, Chromosome 8 breakpoint far 3′ of the c-myc oncogene in a Burkitt lymphoma 2;8 variant translocation is equivalent to the murine pvt-1 locus. EMBO J. 1986;5:2845.
40. Shtivelman E, Henglein B, Groitl P, Lipp M, Bishop JM. Identification of a human transcription unit affected by the variant chromosomal translocations 2;8 and 8;22 of Burkitt lymphoma. Proc Natl Acad Sci U S A. 1989;86:3257.
41. Kasai M, Maziarz RT, Aoki K, Macintyre E, Strominger JL. Molecular involvement of the pvt-1 locus in a gamma/delta T-cell leukemia bearing a variant t(8:14)(q24;q 11) translocation. Mol Cell Biol. 1992;12:4751.